These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21169466)

  • 1. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine.
    Agusti A; Sobradillo P; Celli B
    Am J Respir Crit Care Med; 2011 May; 183(9):1129-37. PubMed ID: 21169466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational bioinformatics and systems biology approaches for personalized medicine.
    Yan Q
    Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?
    Vanfleteren LE; Kocks JW; Stone IS; Breyer-Kohansal R; Greulich T; Lacedonia D; Buhl R; Fabbri LM; Pavord ID; Barnes N; Wouters EF; Agusti A
    Thorax; 2014 Jan; 69(1):72-9. PubMed ID: 23794191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P4 medicine: the future around the corner.
    Sobradillo P; Pozo F; Agustí A
    Arch Bronconeumol; 2011 Jan; 47(1):35-40. PubMed ID: 21190770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COPD control panel: towards personalised medicine in COPD.
    Agusti A; MacNee W
    Thorax; 2013 Jul; 68(7):687-90. PubMed ID: 23117977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Systems biology and personalized medicine - the future is now.
    Auffray C; Hood L
    Biotechnol J; 2012 Aug; 7(8):938-9. PubMed ID: 22887882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toward personalized and integrated treatment of patients with COPD].
    Ancochea J; Gómez García T; de Miguel Díez J
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():14-8. PubMed ID: 21316551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying your body: a how-to guide from a systems biology perspective.
    Smarr L
    Biotechnol J; 2012 Aug; 7(8):980-91. PubMed ID: 22887886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PERSONALIZED MEDICINE: CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATMENT].
    Corhay JL
    Rev Med Liege; 2015; 70(5-6):310-5. PubMed ID: 26285458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From -omics to personalized medicine in nephrology: integration is the key.
    Pesce F; Pathan S; Schena FP
    Nephrol Dial Transplant; 2013 Jan; 28(1):24-8. PubMed ID: 23229923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems medicine and metabolic modelling.
    Mardinoglu A; Nielsen J
    J Intern Med; 2012 Feb; 271(2):142-54. PubMed ID: 22142312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phenotypic heterogeneity of chronic obstructive pulmonary disease].
    Garcia-Aymerich J; Agustí A; Barberà JA; Belda J; Farrero E; Ferrer A; Ferrer J; Gáldiz JB; Gea J; Gómez FP; Monsó E; Morera J; Roca J; Sauleda J; Antó JM;
    Arch Bronconeumol; 2009 Mar; 45(3):129-38. PubMed ID: 19246148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What does endotyping mean for treatment in chronic obstructive pulmonary disease?
    Agustí A; Celli B; Faner R
    Lancet; 2017 Sep; 390(10098):980-987. PubMed ID: 28872030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complexity in chronic obstructive pulmonary disease. Individualized treatment, new approaches, phenotypes and comorbidities].
    Martín-Escudero JC
    Rev Clin Esp; 2011 Mar; 211 Suppl 2():13-21. PubMed ID: 21596169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From pharmacogenomics and systems biology to personalized care: a framework of systems and dynamical medicine.
    Yan Q
    Methods Mol Biol; 2014; 1175():3-17. PubMed ID: 25150863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems medicine: helping us understand the complexity of disease.
    Vandamme D; Fitzmaurice W; Kholodenko B; Kolch W
    QJM; 2013 Oct; 106(10):891-5. PubMed ID: 23904523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers.
    Goh F; Shaw JG; Savarimuthu Francis SM; Vaughan A; Morrison L; Relan V; Marshall HM; Dent AG; O'Hare PE; Hsiao A; Bowman RV; Fong KM; Yang IA
    Expert Rev Respir Med; 2013 Dec; 7(6):593-605. PubMed ID: 24160750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine--a critical view.
    Lopez-Campos JL; Bustamante V; Muñoz X; Barreiro E
    COPD; 2014 Sep; 11(5):591-602. PubMed ID: 24914771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypes and disease characterization in chronic obstructive pulmonary disease. Toward the extinction of phenotypes?
    Agustí A
    Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S125-30. PubMed ID: 24313762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational implications of inflammatory biomarkers and cytokine networks in psychoneuroimmunology.
    Yan Q
    Methods Mol Biol; 2012; 934():105-20. PubMed ID: 22933143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.